Table 2.
Children with positive allergy work‐up to two culprit drugs
| Patient/Gender | Age (years) | Clinical manifestation | Culprit drugs | Patch test | Intradermal test delayed reading | DPT |
|---|---|---|---|---|---|---|
| 1/F | 16 | U | Cephalexin | neg | pos | np |
| UA | Ceftriaxone | neg | pos | np | ||
| 2/F | 4 | UA | Cephalexin | neg | pos | np |
| UA | Ceftriaxone | neg | pos | np | ||
| 3/M | 5 | U | AM | neg | pos | np |
| U | Ceftriaxone | neg | pos | np | ||
| 4/M | 4 | U | AM | pos | neg | np |
| U | Ceftriaxone | neg | neg | U/24 h | ||
| 5/M | 4 | U | BP | neg | pos | np |
| U | Ceftriaxone | neg | pos | np | ||
| 6/Fa | 8 | SJS | BP | pos | np | np |
| SJS | Ceftriaxone | neg | pos | np |
U, urticaria; UA, urticaria and angioedema; SJS, Stevens–Johnson syndrome; DPT, drug provocation tests; np, not performed; pos, positive; neg, negative; BP, benzylpenicillin; AM, ampicillin.
a
This case has been previously described (reference 32).
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.